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In parallel to the tremendous leap achieved by Growth Factor-assisted Distrac-
tion Osteogenesis and Histiogenesis,1 recent developments in the application of 
nanotechnology seem to widely-open the doors for further advances in the fields 
of biomaterials, drug delivery, tissue engineering and regenerative medicine. In 
deed, nanotechnology, first introduced over half a century ago, helps, at a funda-
mental level, to manipulate distinct atoms and molecules to design and produce 
novel structures and materials (size scale ranging 1-1000nm) with unique, im-
proved or desirable physico-chemical, biological and mechanical characteristics 
and properties. Hence, such an emerging field is rendered diverse, multi- and 
inter-disciplinary, where it involves the need for a decent understanding of bio-
logy, chemistry, physics, and mathematics, at the least. On the other hand, na-
nobiotechnology (or bio-nano-technology), refers to scientific and technological 
advances in the intersecting fields of health care and biology, with an emphasis on 
their interface with nano-scale sciences. 
In dentistry, nanotechnology and nanobiotechnology have recently drawn 
the attention of scientists and clinicians to potentially-significant advances 
in the detection, prediction, diagnosis, treatment and prevention of oral and 
maxillofacial diseases; deemed an un-avoidable development (and need) for 
the progress of our art-based-on-science field. Indeed, nanoDentistry2 is de-
fined today as the science and technology of maintaining near-perfect oral 
health using nanomaterials, nanodiagnostics and nanorobotics, alongside the 
application of principles of pharmaceutics, tissue engineering and regenerative 
medicine. For instance, nanomaterials are studied to overcome the physical, 
chemical and mechanical characteristics of conventional dental materials. 
It is projected that nanoDentistry possesses a significant potential to emerge and 
yield (soon) a new generation of technologically-advanced clinical tools and devi-
ces for dento-oral and maxilla-facial healthcare, including: nanorobotic localized 
analgesics (for greater control, patient safety and comfort); nanorobotic dentifrice 
(for superior and halitosis-free oral health care); orthodontic nanorobots (for rapid 
and painless tooth movement without need for braces); bio-nano-enamel (nanorod 
-like calcium hydroxyapatite crystals arranged in parallel); nano-electro-mechanical 
systems (for oral cancer detection and diagnosis); nanovectors and dendrimer nano-
particles (for gene and drug delivery in the treatment of oral cancer) and much more 
“smart” nanobiomaterials under development for cartilage endodontic pulp repair, 
periodontal ligament regeneration, extraction socket preservation and restoration, 
salivary gland radioprotection, implant osseointegration, cartilage regeneration of 
the temporomandibular joint and the treatment of oro-facial fractures, to list a few. 
So, bone augmentation and osteodistraction cannot be excluded applications.1
Explicitly, nano-sized particles made from synthetic polymers and natural poly-
mers are dosage forms that have consummated much attention for the localized 
and release-controlled delivery of growth factors due to their attractive tendency 
to amass in sites of inflammation.3,4 Compared to microparticles, nanoparticle and 
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nanofiber delivery systems have demonstrated superiority in terms 
of longer residencies in general circulation, consequently exten-
ding the bioactivity of the entrapped molecule.3,4 In a good exam-
ple of a combined localized and release-controlled delivery system, 
PLGA nanospheres (NS) immobilized onto prefabricated nanofi-
brous PLLA scaffolds were used to load and deliver rhBMP-7.3 
OP-1 delivered from NS-scaffolds induced significant ectopic 
bone formation while passive adsorption of the protein into the 
scaffold resulted in failure of bone induction either due to the 
loss of protein bioactivity or its rapid release from the scaffolds 
upon implantation in vivo. Our core-shell nanoparticulate deli-
very system formulated via the layer-by-layer (L-b-L) electrosta-
tic-based self-assembly of a shell of alternating layers of anionic. 
The bioactivity of released (linear and multi-step over an exten-
ded period of 45 days) rhBMP-7, controlled through the L-b-L 
design, was maintained via enhancing pre-osteoblast differentia-
tion. Further, the increase in shell thickness slowed the rate of 
protein diffusion compared to faster burst release from uncoated 
liposomal cores.5 
In our rabbit model of tibial distraction osteogenesis, ac-
celerated osteogenesis was evident following a single injection 
of the nanoparticles loaded with a dose of no more than 1μg 
rhBMP-7 in comparison to earlier results from a single injec-
tion of rhBMP-7 (75μg in saline), accentuating the role of the 
injectable localized and release-controlled nanoparticles.6 Other 
groups have been increasingly investigating injectable scaffolds 
for drug delivery; in situ. A fine example is the work of Hasirci 
and co-workers where they developed over the years several 3-D 
scaffolds for the sequential delivery of BMPs.7 
One system consisted of microspheres of polyelectrolyte 
complexes of poly(4-vinyl pyridine) and alginate loaded with 
both proteins and incorporated in PLGA scaffolds. While nei-
ther cytokine delivery had any direct effect on cellular prolife-
ration; their co-administration enhanced osteogenic differen-
tiation to a higher degree than single administration. This was 
suggested to be due to the physical properties (pore size and 
distribution) of the foams. 
It is safe, today, to point out that injectable and multiple 
growth factor delivery systems are mounting interest as they 
could provide a less invasive method for the regeneration and 
repair of osseous defects with clinical indications including 
fresh fractures, non-union or delayed union, large bone de-
fects associated with osseous tumor resection as well as the 
acceleration of periodontal therapy hence avoiding extensi-
ve/secondary surgery and in some cases, even shortening the 
overall treatment period.3-6,8,9 
Nonetheless, since growth factors act in a coordinated casca-
de of events to restore bone, delivering multiple combinations of 
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growth factors should be approached with caution regarding the 
choice of specific morphogens. For example, the sequential re-
lease of BMP-2 in combination with IGF-1 has already been ex-
plored, yet with commercialization-related difficulties. rhBMP-2 
and bFGF absorbed to a collagen sponge resulted in decreased 
bone formation in a rabbit model of tibial fracture.4 
Today, for orthopaedic and craniofacial reconstruction, the 
challenge remains to deliver osteoinductive growth factors in ways 
that would ensure consistent clinical success in humans (function 
and esthetic). BMP therapy should focus on the development of 
customizable, localized and release-controlled delivery materials 
and systems with the surgical practicality (preferably, injectable) 
and adjustable simultaneous growth factor(s) release profiles, ac-
cording to defect site, size and vascularity. 
Indeed, given the complex nature – and microenvironment 
– of osseoregeneration, it is possible that multiple growth factor 
delivery exhibiting both stimulatory and inhibitory responses 
on bone formation (variable release characteristics in response 
to physiological requirements) be the best-fit solution clinically, 
with caution to the choice of combinations. 
Reported pre-clinical and clinical bone tissue engineering 
and regeneration, while satisfactory, can still be controversial. 
Yet, we can agree that efficacy, time and cost continue as main 
limitations. This is especially true in the case of distraction 
osteogenesis. Indeed, the focal question is: “ how to accelerate 
the osteodistraction procedure, in general, and the consolidation 
of regenerate bone, in specific, so that the fixator can be removed 
at an earlier time?” 
Further, “in mandibular osteodistraction, specifically (in 
comparison to endochondral long bone osteodistraction), what 
are the underlying governing mechanisms for enhanced de novo 
intramembranous osseoregeneration?” At BioMAT’X-Chile 
(Available at http://www.uandes.cl/facultad-de-medicina/biomateria-
les-laboratorio-de-ingenieria-de-tejidos-craneo-maxilo-facial.html), 
we are focused to pursue and attempt to tackle such questions.
In parallel, innovating the “ideal” osteo-/osseo-regenerative 
biomaterial, preferably injectable, remains our prime need and 
challenge. The future of osteo-/osseo-distraction (and skeletal 
bone-related health, in general) will closely rely on translational 
nanoMedicine and nanoDentistry with smart and/or intelligent, 
safe and effective nanobiomaterials and nano-based systems 
that combine customizable agent loading, encapsulation, active 
targeting, pre-/post-diagnostic imaging and multi-load release 
pharmacokinetics: a highly-anticipated and eagerly-awaited pa-
radigm shift in endochondral (indirect) and intramembranous 
(direct) de novo bone tissue ossification, engineering and regene-
ration. To re-emphasize, today, this calls for a critical understan-
ding of the cellular and molecular fundamental basis governing 
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the mechanically-induced biological interaction between the 
cells in play and the nano-systems. In parallel, for a perfect-
ly-coordinated osteogenesis, best-fit animal model(s) are lacking. 
Our earlier work also identified DKK-1 (a negative re-
gulator of Wnt signaling) as a target for Wnt/β-catenin 
signaling pathway modulation. Ongoing research at Bio-
MAT’X-Chile, employs a unique, high-value and complex 
animal model of “mandibular” distraction osteogenesis and 
histiogenesis to elucidate the underlying cellular and mole-
cular mechanisms of hard and soft tissue regeneration and 
repair under mechanical stress, following the local and sin-
gle administration of a release-controlled nano-hydrogel hy-
brid loaded with modified core-shell nanocapsules into the 
distracted gap as a “miRNA-mediated DKK-1 gene silen-
cing delivery system” to safely control and locally modulate 
the Wnt/β-catenin signaling pathway. 
We expect this approach would help better understand the 
underlying bio-mechanisms, reveal and identify clinical targets 
for use in the design and development of novel, safe and effective 
therapies, thereby improving current methods and/or introdu-
cing alternative clinical strategies, primarily, in terms of quality, 
quantity and rate, of de novo hard and soft tissue healing, in 
the cranio-oro-maxillo-facial complex, with a multidisciplinary 
bench-top to bed-side translational vision.
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